The genotype-phenotype association of CYP3A4 and CYP3A5 polymorphisms to midazolam clearance in vivo

被引：0
|
作者：
He, P [1 ]
Court, MH [1 ]
Greenblatt, DJ [1 ]
von Moltke, LL [1 ]
机构：
[1] Tufts Univ, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2004年 / 44卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
103
引用
收藏
页码：1209 / 1209
页数：1
相关论文
共 50 条
  • [31] The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
    Topletz, Ariel R.
    Dennison, Jennifer B.
    Barbuch, Robert J.
    Hadden, Chad E.
    Hall, Stephen D.
    Renbarger, Jamie L.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (09) : 1651 - 1661
  • [32] Expression and localization of CYP3A4 and CYP3A5 in human lung
    Anttila, S
    Hukkanen, J
    Hakkola, J
    Stjernvall, T
    Beaune, P
    Edwards, RJ
    Boobis, AR
    Pelkonen, O
    Raunio, H
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (03) : 242 - 249
  • [33] Selective expression of CYP3A5 and not CYP3A4 in human blood
    Janardan, SK
    Lown, KS
    SchmiedlinRen, P
    Thummel, KE
    Watkins, PB
    PHARMACOGENETICS, 1996, 6 (05): : 379 - 385
  • [34] Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
    Williams, JA
    Ring, BJ
    Cantrell, VE
    Jones, DR
    Eckstein, J
    Ruterbories, K
    Hamman, MA
    Hall, SD
    Wrighton, SA
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (08) : 883 - 891
  • [35] CYP3A5 and not CYP3A4 is present in peripheral blood.
    Janardan, SK
    Lown, KS
    SchmiedlinRen, P
    Watkins, PB
    GASTROENTEROLOGY, 1996, 110 (04) : A1222 - A1222
  • [36] Genetic polymorphisms of the CYP3A4, CYP3A5, CYP3A7 and CYP1A2 among the Jordanian population
    Salameh, Ghada
    Al Hadidi, Kamal
    El Khateeb, Mohammad
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2012, 34 (01) : 23 - 33
  • [37] CYP3A5 Genotype-Phenotype Analysis in the Human Kidney Reveals a Strong Site-Specific Expression of CYP3A5 in the Proximal Tubule in Carriers of the CYP3A5*1 Allele
    Bolbrinker, Juliane
    Seeberg, Stefanie
    Schostak, Martin
    Kempkensteffen, Carsten
    Baelde, Hans
    de Heer, Emile
    Kreutz, Reinhold
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (04) : 639 - 641
  • [38] Genetic association in CYP3A4 and CYP3A5 genes elevate the risk of prostate cancer
    Bellah, Sm Faysal
    Salam, Md. Abdus
    Billah, S. M. Saker
    Karim, Md Rezaul
    ANNALS OF HUMAN BIOLOGY, 2023, 50 (01) : 63 - 74
  • [39] Prediction of tacrolimus metabolism and dosage requirements based on CYP3A4 phenotype and CYP3A5*3 genotype in Chinese renal transplant recipients
    Xi Luo
    Li-jun Zhu
    Ning-fang Cai
    Li-yun Zheng
    Ze-neng Cheng
    Acta Pharmacologica Sinica, 2016, 37 : 555 - 560
  • [40] Effect of CYP3A4 and CYP3A5 Genetic Polymorphisms on the Pharmacokinetics of Sirolimus in Healthy Chinese Volunteers
    Zhang, Jing
    Dai, Ying
    Liu, Zhihong
    Zhang, Minxin
    Li, Chen
    Chen, Dingxiong
    Song, Hongtao
    THERAPEUTIC DRUG MONITORING, 2017, 39 (04) : 406 - 411
12345